The estimated Net Worth of Barbara Dalton is at least $9.84 Millón dollars as of 16 March 2020. Barbara Dalton owns over 312,500 units of Imara Inc stock worth over $9,844,803 and over the last 5 years Barbara sold IMRA stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Barbara Dalton IMRA stock SEC Form 4 insiders trading
Barbara has made over 1 trades of the Imara Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Barbara bought 312,500 units of IMRA stock worth $5,000,000 on 16 March 2020.
The largest trade Barbara's ever made was buying 312,500 units of Imara Inc stock on 16 March 2020 worth over $5,000,000. On average, Barbara trades about 104,167 units every 0 days since 2020. As of 16 March 2020 Barbara still owns at least 1,557,722 units of Imara Inc stock.
You can see the complete history of Barbara Dalton stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Imara Inc
Over the last 5 years, insiders at Imara Inc have traded over $7,889,059 worth of Imara Inc stock and bought 11,496,717 units worth $107,874,489 . The most active insiders traders include David M Mott, Lundbeck A S H y Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of $1,965,179. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth $46,028.
What does Imara Inc do?
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.
What does Imara Inc's logo look like?
Complete history of Barbara Dalton stock trades at Imara Inc
Imara Inc executives and stock owners
Imara Inc executives and other stock owners filed with the SEC include:
-
Rahul D. Ballal,
Chief Executive Officer -
Edward R. Conner,
Director -
Enterprise Associates 14, L...,
-
Springs Capital Management ...,
-
Lundbeck A S H,
10% owner -
City Capital Llc Bay City C...,
-
Venture Investments, Llc Al...,
10% owner -
Invest A/S Lundbeckfond,
10% owner -
Bioscience Plc Arix Bioscie...,
-
Capital Management, L.P.Ra ...,
-
Advisors Llc Orbi Med Capit...,
-
James G Mc Arthur,
Director -
Carlbay City Capital Llc Ba...,
-
Mette Kirstine Agger,
Director -
David P Bonita,
Director -
Barbara Dalton,
Director -
Sara M. Nayeem,
Director -
David M Mott,
Director -
Inc Pfizer Ventures (Us) Ll...,
-
Enterprise Associates 14, L...,
-
Michael Gray,
CFO & COO -
Kenneth Attie,
SVP, CMO -
Laura A Williams,
Director -
Carl Goldfischer,
Director -
Mark Chin,
Director -
Advisors Llc Orbi Med Capit...,
-
Braden Michael Leonard,
10% owner -
Enterprise Associates 14, L...,
-
Enterprise Associates 14, L...,
-
Enterprise Associates 14, L...,
-
Capital Lp Commodore,
10% owner